Provided by Tiger Trade Technology Pte. Ltd.

Creative Medical Technology Holdings, Inc.

0.9346
-0.0306-3.17%
Volume:99.36K
Turnover:93.26K
Market Cap:7.10M
PE:-0.48
High:0.9800
Open:0.9300
Low:0.8820
Close:0.9652
52wk High:6.25
52wk Low:0.6200
Shares:7.59M
Float Shares:7.56M
Volume Ratio:0.37
T/O Rate:1.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9543
EPS(LYR):-2.5200
ROE:-77.88%
ROA:-47.32%
PB:0.82
PE(LYR):-0.37

Loading ...

Top Premarket Decliners

MT Newswires Live
·
Jun 26

Creative Medical Files for Securities Offering

MT Newswires Live
·
Jun 26

Creative Medical files to sell 3.05M shares of common stock

TIPRANKS
·
Jun 26

Creative Medical expands ADAPT trial under new FDA clearance

TIPRANKS
·
Jun 22

Creative Medical wins FDA clearance to expand ADAPT trial of Olastrocel in chronic lower back pain

Reuters
·
Jun 22

Creative Medical Technology Holdings Expands Adapt Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain

THOMSON REUTERS
·
Jun 22

Creative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain

GlobeNewswire
·
Jun 22

Creative Medical advances Project PHOENIX burn pit exposure registry into nationwide AI-driven virtual data collection phase

Reuters
·
Jun 16

Creative Medical Technology Holdings, Inc. Advances Project PHOENIX into Nationwide AI Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazards

GlobeNewswire
·
Jun 16

Creative Medical Tech Q1 EPS $(0.38) Beats $(0.39) Estimate

Benzinga Earnings
·
May 09

Creative Medical Technology Holdings Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 09

Creative Medical net loss narrows 14.31% to $1.4 million in Q1 FY26

Reuters
·
May 09

Creative Medical Technology Holdings Inc expected to post a loss of 39 cents a share - Earnings Preview

Reuters
·
May 06

Creative Medical knee data ‘highly positive,’ says Roth Capital

TIPRANKS
·
Apr 28

Creative Medical reports pilot study of Ultrasome meets priamry endpoint

TIPRANKS
·
Apr 28

Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies

GlobeNewswire
·
Apr 28